The stock price of Unitedhealth Group Inc (NYSE: UNH) has plunged by -0.57 when compared to previous closing price of 441.72, but the company has seen a -3.63% decline in its stock price over the last five trading sessions. WSJ reported 2024-04-14 that Investors might get a better sense of the fallout for UnitedHealth Group when it reports first-quarter earnings results Tuesday.
Is It Worth Investing in Unitedhealth Group Inc (NYSE: UNH) Right Now?
Unitedhealth Group Inc (NYSE: UNH) has a higher price-to-earnings ratio of 18.42x compared to its average ratio. UNH has 36-month beta value of 0.57. Analysts have mixed views on the stock, with 11 analysts rating it as a “buy,” 11 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for UNH is 920.22M, and currently, short sellers hold a 0.84% ratio of that float. The average trading volume of UNH on April 15, 2024 was 4.45M shares.
UNH’s Market Performance
The stock of Unitedhealth Group Inc (UNH) has seen a -3.63% decrease in the past week, with a -10.00% drop in the past month, and a -18.62% fall in the past quarter. The volatility ratio for the week is 1.57%, and the volatility levels for the past 30 days are at 1.46% for UNH. The simple moving average for the last 20 days is -7.81% for UNH stock, with a simple moving average of -13.59% for the last 200 days.
Analysts’ Opinion of UNH
Many brokerage firms have already submitted their reports for UNH stocks, with HSBC Securities repeating the rating for UNH by listing it as a “Hold.” The predicted price for UNH in the upcoming period, according to HSBC Securities is $460 based on the research report published on April 04, 2024 of the current year 2024.
Barclays, on the other hand, stated in their research note that they expect to see UNH reach a price target of $551. The rating they have provided for UNH stocks is “Overweight” according to the report published on March 06th, 2024.
HSBC Securities gave a rating of “Reduce” to UNH, setting the target price at $480 in the report published on December 18th of the previous year.
UNH Trading at -11.05% from the 50-Day Moving Average
After a stumble in the market that brought UNH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -20.82% of loss for the given period.
Volatility was left at 1.46%, however, over the last 30 days, the volatility rate increased by 1.57%, as shares sank -10.18% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -14.18% lower at present.
During the last 5 trading sessions, UNH fell by -3.63%, which changed the moving average for the period of 200-days by -8.99% in comparison to the 20-day moving average, which settled at $473.93. In addition, Unitedhealth Group Inc saw -16.58% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at UNH starting from McSweeney Erin, who sale 1,236 shares at the price of $483.48 back on Mar 08 ’24. After this action, McSweeney Erin now owns 9,364 shares of Unitedhealth Group Inc, valued at $597,582 using the latest closing price.
ROOS THOMAS E, the Chief Accounting Officer of Unitedhealth Group Inc, sale 858 shares at $525.79 during a trade that took place back on Feb 23 ’24, which means that ROOS THOMAS E is holding 32,289 shares at $451,128 based on the most recent closing price.
Stock Fundamentals for UNH
Current profitability levels for the company are sitting at:
- 0.09 for the present operating margin
- -1.52 for the gross margin
The net margin for Unitedhealth Group Inc stands at 0.06. The total capital return value is set at 0.18. Equity return is now at value 26.88, with 8.47 for asset returns.
Based on Unitedhealth Group Inc (UNH), the company’s capital structure generated 0.42 points at debt to capital in total, while cash flow to debt ratio is standing at 0.46. The debt to equity ratio resting at 0.72. The interest coverage ratio of the stock is 9.97.
Currently, EBITDA for the company is 36.33 billion with net debt to EBITDA at 1.22. When we switch over and look at the enterprise to sales, we see a ratio of 1.21. The receivables turnover for the company is 9.49for trailing twelve months and the total asset turnover is 1.33. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.79.
Conclusion
To put it simply, Unitedhealth Group Inc (UNH) has had a bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
